Deanna L. Kirkpatrick
Lawyers
Filters
Toronto-Dominion Bank $100 million notes offering
The investment-grade notes are due 2028
Toronto-Dominion Bank $2 billion notes offering
The investment-grade debt offering consists of two tranches
Prometheus Biosciences $500 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Akoya Biosciences $50 million at-the-market program
The common stock is listed on the Nasdaq Global Select Market
Immatics $110 million follow-on offering
We advised Immatics on the offering of shares
Solid Biosciences $75 million common stock PIPE offering
The financing is taking place concurrently with the company’s acquisition of AavantiBio
Medtronic Global Holdings €3.5 billion notes offering
The investment-grade notes were issued in four tranches
Toronto-Dominion Bank $3 billion notes offering
The investment-grade debt offering consists of two tranches
Export Development Canada $3.25 billion global bond offering
The investment-grade bonds are due 2025
ADC Therapeutics $175 million term loan facility and other financings
We advised the company on the new facility, a $115 million exchange and a $6.25 million share sale